366
Participants
Start Date
November 30, 2008
Primary Completion Date
April 30, 2010
Study Completion Date
November 30, 2010
Placebo
Non-active tablet identical to study drug tablets
2400mg SPN-804
tablets containing 600mg OXC XR, identical to non-active tablets
1200mg SPN-804
two active tablets and two non-active tablets, all identical
Huntsville
Northport
Phoenix
Tucson
Little Rock
Riverside
West Los Angeles
Aurora
Jacksonville
Miami
Sarasota
Atlanta
Springfield
Lexington
Bethesda
Missoula
Camden
New York
Oklahoma City
Philadelphia
Nashville
Baytown
Temple
Blagoevgrad
Pleven
Plovdiv
Rousse
Sofia
Varna
Edmonton
Greenfield Park
Dubrovnik
Rijeka
Zadar
Zagreb
Aguascalientes
Chihuahua City
Ciudad Juárez
Durango
Guadalajara
Zapopan
Mexico City
Monterrey
Puebla City
San Luis Potosí City
Toluca
Giżycko
Gmina Końskie
Katowice
Krakow
Lodz
Lublin
Warsaw
Wilkowice
Zabrze
Bucharest
Campulung Muscel
Cluj-Napoca
Craiova
Saint Petersburg
Kazan'
Kirov
Kursk
Moscow
Nizhny Novgorod
Novosibirsk
Pyatigorsk
Saint Petersburg
Samara
Smolensk
Yaroslavl
Collaborators (1)
Parexel
INDUSTRY
Supernus Pharmaceuticals, Inc.
INDUSTRY